<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="psp412554-fig-0001" orientation="portrait" position="float">
 <label>Figure 1</label>
 <caption>
  <p>Characteristics of PPK or PPKPD (ER) analysis in NMEs for new active ingredients that were approved from JFY 2014 to JFY 2018 in Japan. Bars in gray and bars in white indicate the number of NMEs, which include reports on PPK analysis and reports on PPKPD (ER) analysis, respectively. The line chart with solid and dashed line indicate the percent of NMEs, which include reports on PPK analysis and reports on PPKPD (ER) analysis, respectively. PPK, population pharmacokinetic; PPKPD (ER) analysis, population pharmacokinetic/pharmacodynamics analysis or exposure‚Äêresponse analysis; NME, new molecular entity; JFY, Japanese fiscal year.</p>
 </caption>
 <graphic id="nlm-graphic-1" xlink:href="PSP4-9-550-g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
